← Leaderboards
Fernando A Gonzalez
University Of Puerto Rico Rio Piedras
$4,164,057
Attributed
$4,164,057
Total exposure
20
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1M · FY2005–10$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$27,821,875 · 21
By mechanism
P20$25,879,165 · 17
S06$1,604,090 · 1
G12$338,620 · 2
R24$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Receptor Coupling”
- Ehud Isacoff · University Of California Berkeley$29,075,152
- Brian K Kobilka · Stanford University$28,466,252
- Stanley J Opella · Wistar Institute$24,727,853
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$24,392,843
- Raymond C Stevens · University Of Calif-Lawrenc Berkeley Lab$23,957,001
- Roger Brent · Molecular Sciences Institute$23,816,719
Research focus
Receptor CouplingReceptor ExpressionImmunoprecipitationBiological Signal TransductionPuerto RicoNucleotidesHuman TissuePurinergic ReceptorVisitResourcesUnited States National Institutes Of HealthSourceFacultyProgramsFundingNeoplastic Cell Culture For Noncancer ResearchGrantInstitutionPhosphorylationResearch PersonnelMinority Institution Research SupportComputer Retrieval Of Information On Scientific Projects DatabaseWestern BlottingsHealth Science Research Support
Grant awards (50)
PRAABRE: ADMINISTRATIVE CORE$233,251
P20 · FY2010 · RR · contact PI
TECHNOLOGY TRANSFER TRAVEL AWARDS$56,114
P20 · FY2010 · RR · contact PI
PRAABRE: ADMINISTRATIVE CORE$147,527
P20 · FY2009 · RR · contact PI
TECHNOLOGY TRANSFER TRAVEL AWARDS$35,491
P20 · FY2009 · RR · contact PI
Advancing Competitive Biomedical Research in Puerto Rico$3,352,598
P20 · FY2008 · RR · contact PI
PRAABRE: ADMINISTRATIVE CORE$222,277
P20 · FY2008 · RR · contact PI
TECHNOLOGY TRANSFER TRAVEL AWARDS$53,474
P20 · FY2008 · RR · contact PI
Advancing Competitive Biomedical Research in Puerto Rico$3,206,001
P20 · FY2007 · RR · contact PI
P2Y2 Purinergic Receptor Signaling and Membrane Microdomains$389,905
S06 · FY2007 · GM · contact PI
PRAABRE: ADMINISTRATIVE CORE$190,951
P20 · FY2007 · RR · contact PI
TECHNOLOGY TRANSFER TRAVEL AWARDS$88,100
P20 · FY2007 · RR · contact PI
Advacing Competitive Biomedical Research in Puerto Rico$3,483,516
P20 · FY2006 · RR · contact PI
BRIN: UPR: ADMINISTRATIVE CORE$319,647
P20 · FY2006 · RR · contact PI
P2Y2 Purinergic Receptor and Membrane Microdomains$200,003
S06 · FY2006 · GM · contact PI
TECHNOLOGY TRANSFER TRAVEL AWARDS$58,628
P20 · FY2006 · RR · contact PI
Advacing Competitive Biomedical Research in Puerto Rico$3,545,405
P20 · FY2005 · RR
BRIN: UPR: ADMINISTRATIVE CORE$273,351
P20 · FY2005 · RR
P2Y2 Purinergic Receptor and Membrane Microdomains$194,178
S06 · FY2005 · GM
TECHNOLOGY TRANSFER TRAVEL AWARDS$68,036
P20 · FY2005 · RR
Advancing Competitive Biomedical Research in Puerto Rico$2,030,322
P20 · FY2004 · RR
PR COBRE: P2Y2 NUCLEOTIDE RECEPTOR IN ISCHEMIA$382,668
P20 · FY2004 · RR
P2Y2 Purinergic Receptor and Membrane Microdomains$158,366
S06 · FY2004 · GM
BRIN: UPR: ADMINISTRATIVE CORE$82,695
P20 · FY2004 · RR
TECHNOLOGY TRANSFER TRAVEL AWARDS$9,137
P20 · FY2004 · RR
BIOMEDICAL RESEARCH INFRASTRUCTURE NETWORK--PUERTO RICO$3,020,851
P20 · FY2003 · RR
BIOMEDICAL RESEARCH INFRASTRUCTURE NETWORK--PUERTO RICO$1,994,843
P20 · FY2002 · RR
Supplement for BRIN-PR Project R20 RR16470-01$1,028,057
P20 · FY2002 · RR
DESENSITIZATION OF P2Y2 NUCLEOTIDE RECEPTOR &CF THERAPY$110,273
S06 · FY2002 · GM
DESENSITIZATION OF P2Y2 NUCLEOTIDE RECEPTOR &CF THERAPY$110,273
S06 · FY2002 · GM
DESENSITIZATION OF P2Y2 NUCLEOTIDE RECEPTOR &CF THERAPY$110,273
S06 · FY2002 · GM
DESENSITIZATION OF P2Y2 NUCLEOTIDE RECEPTOR &CF THERAPY$110,273
S06 · FY2002 · GM
A 3-FACTOR MODEL OF DRUG EFFECTS ON OPERANT RESPONDING$0
R24 · FY2002 · DA
P2 NUCLEOTIDE RECEPTORS IN IMMUNE SYSTEM$0
G12 · FY2002 · RR
BIOTESTING &ENZYME ACT: POTENTIAL ANTIVIRAL, ANTICANCER, NEUROTOXIC DRUGS$0
G12 · FY2002 · RR
CORE--INSTRUMENTATION$0
P20 · FY2002 · RR
CORE--INSTRUMENTATION$0
P20 · FY2002 · RR
P2Y2 NUCLEOTIDE RECEPTOR IN ISCHEMIA$0
P20 · FY2002 · RR
P2Y2 NUCLEOTIDE RECEPTOR IN ISCHEMIA$0
P20 · FY2002 · RR
BIOMEDICAL RESEARCH INFRASTRUCTURE NETWORK--PUERTO RICO$1,996,225
P20 · FY2001 · RR
DESENSITIZATION OF P2Y2 NUCLEOTIDE RECEPTOR &CF THERAPY$110,273
S06 · FY2001 · GM
P2 NUCLEOTIDE RECEPTORS IN IMMUNE SYSTEM$0
G12 · FY2001 · RR
A 3-FACTOR MODEL OF DRUG EFFECTS ON OPERANT RESPONDING$0
R24 · FY2001 · DA
CORE--INSTRUMENTATION$0
P20 · FY2001 · RR
P2Y2 NUCLEOTIDE RECEPTOR IN ISCHEMIA$0
P20 · FY2001 · RR
BIOTESTING &ENZYME ACT: POTENTIAL ANTIVIRAL, ANTICANCER, NEUROTOXIC DRUGS$0
G12 · FY2001 · RR
P2 NUCLEOTIDE RECEPTORS IN IMMUNE SYSTEM$170,412
G12 · FY2000 · RR
BIOTESTING &ENZYME ACT: POTENTIAL ANTIVIRAL, ANTICANCER, NEUROTOXIC DRUGS$168,208
G12 · FY2000 · RR
DESENSITIZATION OF P2Y2 NUCLEOTIDE RECEPTOR &CF THERAPY$110,273
S06 · FY2000 · GM
CORE--INSTRUMENTATION$0
P20 · FY2000 · RR
P2Y2 NUCLEOTIDE RECEPTOR IN ISCHEMIA$0
P20 · FY2000 · RR